Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti–PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial

Skip to main content

Open Access Publications from the University of California

Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti–PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial

2022

Published Web Location

https://doi.org/10.1200/jco.21.02904

Creative Commons 'BY' version 4.0 license

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.